I
Inhibikase Therapeutics D
D
IKT
1.68000
USD
-0.05
(-2.61%)
مغلق
حجم التداول
12,059
الربح لكل سهم
-0
العائد الربحي
-
P/E
-3
حجم السوق
124,893,787
العنوان: Inhibikase Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.